End-of-day prices provided by Twelve Data · One close per session. Not real time and not a quote.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Declared intent to influence
Filed on Schedule 13D: the investor states an intention to influence how the company is run.
Passive holders
Filed on Schedule 13G: large stakes held without an intention to control — mostly index and institutional funds.
426 filings on record, the oldest from Mar 29, 21.
Sale intention announced
On Jul 6, MPM Oncology Innovations Fund, L.P. filed notice of intent to sell up to $7K. That is about 0.04% of shares outstanding. It is filed under a pre-arranged 10b5-1 plan.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
No sale of theirs is on record yet in Form 4; the 90-day window is still open.
Beta
Scores, historical analogues, watchlist and Radar work over the same companies you can already browse here.
Invite-only beta. Payments are not active yet.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Listing the 25 most recent filings of the 426 on record.
There are 28 more transactions in this stretch.
The full record holds 145 transactions and goes back to Jan 3, 23.
